Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
11.14
-0.13 (-1.15%)
Jan 16, 2026, 4:00 PM EST
Cipher Pharmaceuticals Market Cap
Cipher Pharmaceuticals has a market cap or net worth of $279.58 million as of January 20, 2026. Its market cap has increased by 10.23% in one year.
Market Cap
279.58M
Enterprise Value
284.58M
Revenue
50.06M
Ranking
n/a
PE Ratio
16.10
Stock Price
$11.14
Market Cap Chart
Since February 25, 2004, Cipher Pharmaceuticals's market cap has increased from 58.00M to 279.58M, an increase of 382.07%. That is a compound annual growth rate of 7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 279.87M | 0.41% |
| Dec 31, 2025 | 278.73M | 9.44% |
| Dec 31, 2024 | 254.68M | 152.73% |
| Dec 29, 2023 | 100.77M | 41.37% |
| Dec 30, 2022 | 71.28M | 94.22% |
| Dec 31, 2021 | 36.70M | 86.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |